Solara Active Pharma Sciences Publishes Rights Share Call Advertisement
Solara Active Pharma Sciences has published newspaper advertisements in Business Standard and Pratahkal on March 25, 2026, informing shareholders about the second and final call of ₹112.50 per rights share. The company set April 2, 2026, as the record date for determining eligible shareholders, with proper regulatory filings made to BSE and NSE under SEBI compliance requirements.

*this image is generated using AI for illustrative purposes only.
Rights Issue Committee Decision
Solara Active Pharma Sciences Limited has announced the publication of newspaper advertisements regarding the second and final call on partly-paid rights shares, following the Rights Issue Committee meeting held on March 24, 2026. The pharmaceutical company published advertisements in Business Standard and Pratahkal newspapers on March 25, 2026, informing shareholders about the call details and record date.
Call Amount Structure
The committee has determined a comprehensive call amount structure for the partly-paid rights shares:
| Component: | Amount per Share |
|---|---|
| Face Value: | ₹3.00 |
| Securities Premium: | ₹109.50 |
| Total Call Amount: | ₹112.50 |
Record Date and Process Details
Key details of the rights share call process have been established:
| Parameter: | Details |
|---|---|
| Record Date: | Thursday, April 2, 2026 |
| Purpose: | Determining holders of partly paid-up equity shares |
| Action: | Call notices dispatch to eligible shareholders |
| Basis: | Rights shares under May 9, 2024 Letter of Offer |
| Website Publication: | https://solara.co.in/investor-relations/newspaper-publications |
Stock Exchange Communication
The formal announcement was communicated to both major stock exchanges where the company's shares are listed:
| Exchange: | Details |
|---|---|
| BSE Limited: | Scrip Code 541540, Symbol SOLARA |
| NSE India Limited: | Scrip Code 890202, Symbol SOLARAPP1 |
| Compliance: | Regulation 30 and 42 of SEBI LODR 2015 |
| Filing Date: | March 25, 2026 |
Corporate Governance and Compliance
The intimation was signed by Pooja Jaya Kumar, Company Secretary and Compliance Officer (ICSI Membership No. A57415), ensuring adherence to corporate governance protocols. The communication included detailed regulatory disclosures as required under SEBI guidelines, with the newspaper advertisements being made available on the company's official website for investor reference.
Share Transfer Window Notice
The company has also announced a special window for re-lodgement of transfer requests for physical shares, running from February 5, 2026, to February 4, 2027. This facility is available for shareholders whose transfer requests were rejected or returned due to document deficiencies before March 31, 2021, in compliance with SEBI circular requirements.
How will the ₹112.50 per share call amount impact Solara's cash flow and capital structure once fully collected?
What strategic initiatives or expansion plans does Solara intend to fund with the capital raised from this rights issue completion?
Will the completion of this rights issue affect Solara's debt-to-equity ratio and overall financial leverage in the pharmaceutical sector?

































